These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 4999093)

  • 1. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody responses in serum and nasal secretions according to age of recipient and method of administration of A2-Hong Kong-68 inactivated influenza virus vaccine.
    Fulk RV; Fedson DS; Huber MA; Fitzpatrick JR; Kasel JA
    J Immunol; 1970 Jan; 104(1):8-13. PubMed ID: 4983534
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G; Greenbaum E; Zakay-Rones Z
    Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuraminidase- and hemagglutinin-inhibiting antibodies in serum and nasal secretions of volunteers immunized with attenuated and inactivated influenza B-Eng-13-65 virus vaccines.
    Downie JC
    J Immunol; 1970 Sep; 105(3):620-6. PubMed ID: 5311581
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutralization antibody response to A2 Hong Kong influenza vaccine and its duration in school age children.
    Hosai H; Omura S; Maeda A; Kunita N
    Biken J; 1970 Dec; 13(4):277-87. PubMed ID: 5510350
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine.
    Kasel JA; Hume EB; Fulk RV; Togo Y; Huber M; Hornick RB
    J Immunol; 1969 Mar; 102(3):555-62. PubMed ID: 5773312
    [No Abstract]   [Full Text] [Related]  

  • 8. Influenza antibody response following aerosal administration of inactivated virus.
    Waldman RH; Wood SH; Torres EJ; Small PA
    Am J Epidemiol; 1970 Jun; 91(6):574-85. PubMed ID: 5445644
    [No Abstract]   [Full Text] [Related]  

  • 9. [Course of antibodies in men after vaccination with the inactivated influenca vaccine Alorbat (author's transl)].
    Pressler K; Schenk KD
    Med Klin; 1978 Sep; 73(38):1321-6. PubMed ID: 703655
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificity of the local secretory antibody to influenza A virus infection.
    Richman DD; Murphy BR; Tierney EL; Chanock RM
    J Immunol; 1974 Nov; 113(5):1654-6. PubMed ID: 4213978
    [No Abstract]   [Full Text] [Related]  

  • 11. Specificity of respiratory secretion antibody against influenza virus.
    Waldman RH; Wigley FM Small PA
    J Immunol; 1970 Dec; 105(6):1477-83. PubMed ID: 4320734
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antineuraminidase antibodies in influenza infection and vaccination with inactivated vaccines].
    Profeta ML; Zanetti A; Bergamini F
    Boll Ist Sieroter Milan; 1972; 51(3):190-9. PubMed ID: 4653136
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody responses in children and elderly persons following local or parenteral administration of an inactivated influenza virus vaccine, A2-Hong Kong-68 variant.
    Fulk RV; Fedson DS; Huber MA; Fitzpatrick JR; Howar BF; Kasel JA
    J Immunol; 1969 Apr; 102(4):1102-5. PubMed ID: 5768188
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavior of the hemagglutination inhibiting antibodies against the A2 virus, Hong Kong, London 1968 and A2, Singapore in 1957 in patients with influenza disease].
    Signorini C
    G Mal Infett Parassit; 1970 Sep; 22(9):627-30. PubMed ID: 5514055
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunity status of the Milanese population towards B-Hong Kong-8-73, the new B type strain and study of the immunizing activity of the old composition vaccine].
    Profeta ML; Zanetti AR; Bergamini F
    Boll Ist Sieroter Milan; 1973; 52(5):429-35. PubMed ID: 4788200
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
    Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines.
    Slepushkin AN; Schild GC; Beare AS; Chinn S; Tyrrell DA
    J Hyg (Lond); 1971 Dec; 69(4):571-8. PubMed ID: 5002644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revised (1972-1973) bivalent influenza vaccine. Serum and nasal antibody responses to parenteral vaccination.
    Wenzel RP; Hendley JO; Sande MA; Gwaltney JM
    JAMA; 1973 Oct; 226(4):435-8. PubMed ID: 4800234
    [No Abstract]   [Full Text] [Related]  

  • 20. Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine.
    Ogra PL; Karzon DT
    J Immunol; 1969 Jan; 102(1):15-23. PubMed ID: 4303877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.